denkapparat Operations GmbH Invests $309,000 in HCA Healthcare, Inc. (NYSE:HCA)

denkapparat Operations GmbH purchased a new position in HCA Healthcare, Inc. (NYSE:HCAFree Report) during the fourth quarter, Holdings Channel reports. The fund purchased 1,028 shares of the company’s stock, valued at approximately $309,000.

Several other institutional investors have also added to or reduced their stakes in the company. MML Investors Services LLC increased its stake in shares of HCA Healthcare by 31.7% in the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after acquiring an additional 4,285 shares in the last quarter. Meritage Group LP purchased a new stake in HCA Healthcare in the third quarter worth approximately $150,548,000. Galvin Gaustad & Stein LLC bought a new position in shares of HCA Healthcare in the 4th quarter worth approximately $18,044,000. NRI Wealth Management LC bought a new position in shares of HCA Healthcare in the fourth quarter worth about $2,896,000. Finally, Czech National Bank grew its position in shares of HCA Healthcare by 4.5% during the fourth quarter. Czech National Bank now owns 39,543 shares of the company’s stock worth $11,869,000 after purchasing an additional 1,691 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of recent analyst reports. Barclays dropped their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research note on Monday, January 27th. Cantor Fitzgerald restated an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a research note on Monday, January 27th. KeyCorp cut their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Royal Bank of Canada lowered their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research report on Monday, January 27th. Finally, Truist Financial lowered their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.

Check Out Our Latest Stock Analysis on HCA Healthcare

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $341.94 on Friday. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a fifty day moving average price of $323.90 and a two-hundred day moving average price of $341.86. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The company has a market cap of $84.19 billion, a PE ratio of 15.56, a P/E/G ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the firm posted $5.90 EPS. Research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a $0.72 dividend. The ex-dividend date is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.84%. HCA Healthcare’s payout ratio is 13.11%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.